Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Begay-Müller, Valerie Dr. (1) Beule, Dieter Dr. (2) Birchmeier-Kohler, Carmen Prof. Dr. (1) Blüthgen, Nils (1) Bunse, Mario Dr. (1) Chekulaeva, Marina Dr. (2) Daumke, Oliver Prof. Dr. (1) Dittmar, Gunnar Dr. (1) Franke, Vedran Dr. (1) Gerhardt, Holger Prof. Dr. (1) Gotthardt, Michael Prof. Dr. (1) Heuser, Arnd Dr. (1) Hübner, Norbert Prof. Dr. (1) Janz, Martin Dr. (7) Kammertöns, Thomas Dr. (2) Kempa, Stefan Dr. (1) Kieback, Elisa Dr. (3) Kirchner, Marieluise Dr. (1) Kobelt, Dennis Dr. (1) Ku, Min-Chi Dr. (1) Kunz, Severine Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Dr. (3) Lewin, Gary Prof. Dr. (1) Lorenz, Felix Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (7) Milek, Miha Dr. (1) Müller, Thomas Dr. (1) Niendorf, Thoralf Prof. Dr. (1) Ohler, Uwe Prof. Dr. (2) Patone, Giannino Dr. (1) Poncette, Lucia (1) Poulet, James Prof. Dr. (1) Radke, Michael Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Rocks, Oliver Dr. (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (8) Song, Kun Prof. Dr. (1) Specker, Edgar Dr. (1) Uckert, Wolfgang Prof. Dr. (6) von Kries, Jens Peter Dr. (1) Walther, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (2) Woehler, Andrew Dr. (1) Zauber, Henrik Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (26) (-) Daniel, Peter Prof. Dr. (1) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (3) Genetik und Genomik von Herz- Kreislauferkrankungen (2) Integrative Vaskuläre Biologie (1) (-) Molekulare Immunologie und Gentherapie (26) (-) Molekulare Zellbiologie und Gentherapie (3) Translationale Onkologie solider Tumore (2) 1992 (4) 1993 (7) (-) 1994 (5) (-) 1995 (8) (-) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (4) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (13) 2014 (4) 2015 (5) 2016 (4) (-) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (1) 29 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie Molekulare Zellbiologie und Gentherapie19941995199620062017 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Dezember 2017 / Int J Cancer The immune system prevents recurrence of transplanted but not autochthonous antigenic tumors after oncogene inactivation therapy K. Anders O. Kershaw L. Larue A.D. Gruber T. Blankenstein 06. November 2017 / J Exp Med Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity X. Chen L. Poncette T. Blankenstein 15. Oktober 2017 / Clin Cancer Res T cell receptors for clinical therapy: in vitro assessment of toxicity risk A. Kunert M. Obenaus C.H.J. Lamers T. Blankenstein R. Debets 15. September 2017 / Canc Res CTLA4 promotes Tyk2-STAT3 dependent B-cell oncogenecity A. Herrmann C. Lahtz T. Nagao J.Y. Song W.C. Chan H. Lee C. Yue T. Look R. Muelfarth W. Li K. Jenkins J. Williams L.E. Budde S.J. Forman L.W. Kwak T. Blankenstein H. Yu 04. Mai 2017 / Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein 01. Februar 2017 / Canc Immunol Res Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival N.J. Miller C.D. Church L. Dong D. Crispin M.P. Fitzgibbon K. Lachance L. Jing M. Shinohara I. Gavvovidis G. Willimsky M. McIntosh T. Blankenstein D.M. Koelle P. Nghiem 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
15. Dezember 2017 / Int J Cancer The immune system prevents recurrence of transplanted but not autochthonous antigenic tumors after oncogene inactivation therapy K. Anders O. Kershaw L. Larue A.D. Gruber T. Blankenstein
06. November 2017 / J Exp Med Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity X. Chen L. Poncette T. Blankenstein
15. Oktober 2017 / Clin Cancer Res T cell receptors for clinical therapy: in vitro assessment of toxicity risk A. Kunert M. Obenaus C.H.J. Lamers T. Blankenstein R. Debets
15. September 2017 / Canc Res CTLA4 promotes Tyk2-STAT3 dependent B-cell oncogenecity A. Herrmann C. Lahtz T. Nagao J.Y. Song W.C. Chan H. Lee C. Yue T. Look R. Muelfarth W. Li K. Jenkins J. Williams L.E. Budde S.J. Forman L.W. Kwak T. Blankenstein H. Yu
04. Mai 2017 / Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein
01. Februar 2017 / Canc Immunol Res Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival N.J. Miller C.D. Church L. Dong D. Crispin M.P. Fitzgibbon K. Lachance L. Jing M. Shinohara I. Gavvovidis G. Willimsky M. McIntosh T. Blankenstein D.M. Koelle P. Nghiem
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken